FEMRING Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Femring, and when can generic versions of Femring launch?
Femring is a drug marketed by Millicent and is included in one NDA.
The generic ingredient in FEMRING is estradiol acetate. There are seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estradiol acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FEMRING?
- What are the global sales for FEMRING?
- What is Average Wholesale Price for FEMRING?
Summary for FEMRING
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Clinical Trials: | 1 |
Patent Applications: | 514 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FEMRING |
Drug Sales Revenues: | Drug sales revenues for FEMRING |
What excipients (inactive ingredients) are in FEMRING? | FEMRING excipients list |
DailyMed Link: | FEMRING at DailyMed |
![FEMRING drug patent expirations Drug patent expirations by year for FEMRING](/p/graph/s/t/FEMRING-patent-expirations.png)
![Drug Prices for FEMRING](/p/graph/drug-price/FEMRING.png)
![Drug Sales Revenue Trends for FEMRING](/p/graph/drug-sales-revenues/FEMRING.png)
Recent Clinical Trials for FEMRING
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Columbia University | N/A |
Pharmacology for FEMRING
Drug Class | Estrogen |
Mechanism of Action | Estrogen Receptor Agonists |
US Patents and Regulatory Information for FEMRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-001 | Mar 20, 2003 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-002 | Mar 20, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FEMRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-001 | Mar 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-002 | Mar 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FEMRING
See the table below for patents covering FEMRING around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 178204 | ⤷ Sign Up | |
Denmark | 0799025 | ⤷ Sign Up | |
Ireland | S68528 | Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors | ⤷ Sign Up |
China | 1138526 | ⤷ Sign Up | |
Canada | 2207622 | DISPOSITIFS DE LIBERATION INTRAVAGINALE DE MEDICAMENTS POUR L'ADMINISTRATION DE PRECURSEURS D'ESTRADIOL-17.BETA. (INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF17.BETA.-OESTRADIOL PRECURSORS) | ⤷ Sign Up |
Ireland | S950959 | ⤷ Sign Up | |
Argentina | 002010 | UN DISPOSITIVO DE LIBERACION DE DROGA INTRAVAGINAL ADECUADO PARA LA ADMINISTRACION A UN MAMIFERO HEMBRA, UN PROCEDIMIENTO PARA PREPARARLO Y USO DEPRECURSORES DE 17ß-ESTRADIOL EN EL DISPOSITIVO Y PARA LA FABRICACION DEL DISPOSITIVO. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FEMRING
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0136011 | 2000C/027 | Belgium | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
1453521 | C 2015 029 | Romania | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
1453521 | 132016000025143 | Italy | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ED ETINILESTRADIOLO(SEASONIQUE); AUTHORISATION NUMBER(S) AND DATE(S): 17/0017/15-S, 20150211;042139016, 20150414 |
1380301 | CA 2009 00017 | Denmark | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
0770388 | 09C0018 | France | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103 |
0398460 | C300221 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307 |
0398460 | SPC/GB04/032 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |